PEPID Pulse
  • Blog
  • Alerts
  • Press
  • pepid.com
Select Page
FDA Approves First Treatment for Episodic Cluster Headache that Reduces the Frequency of Attacks

FDA Approves First Treatment for Episodic Cluster Headache that Reduces the Frequency of Attacks

by PEPID Newsroom | Jun 4, 2019 | Alerts

Emgality (gacanezumab-gnlm) solution has been FDA approved for treatment of episodic cluster headache in adults, the first of its kind. Emgality was approved in 2018 to prevent migraines in adults, and now has shown to reduce the frequency of cluster headache attaches...

Recent Posts

  • Heart Health Month in Practice: What Clinicians Should Watch for in February
  • National Blood Donor Month: How Clinicians Can Encourage Lifesaving Donations
  • Holiday Health Hazards: Common ER Visits and How to Prevent Them
  • What Is a DNP? Everything You Need to Know About the Doctor of Nursing Practice
  • Halloween Health & Safety: Tips for Families and Clinicians

Categories

  • Alerts
  • Emergency Medicine
  • Featured Posts
  • Nursing
  • Pharmacy
  • Press & Media
  • Primary Care
  • Uncategorized
PEPID, LLC. All rights reserved